TJP1 and Alzheimer disease: During the occurrence and development of AD, the decreased protein levels of ZO-1 and Occludin in brain will lead to structural disorder of vascular endothelial cells, cerebrovascular injury, increased permeability of BBB, and accelerated accumulation of Aβ [44].